| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 605570 | 73599 | OLANZAPINA NORMON 5 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA NORMON 5 mg COMPRIMIDOS BUCODISPERSABLES EFG , 500 comprimidos | 5 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73599/73599_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73599/73599_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2011-08-30 | 1 | 1 | 1 | 2011-08-30 | 2011-08-30 | 1 | 2011-11-21 | View Edit Delete | ||||||||||||
| 605571 | 73600 | OLANZAPINA NORMON 10 mg COMPRIMIDOS BUCODISPERSABLES EFG | OLANZAPINA NORMON 10 mg COMPRIMIDOS BUCODISPERSABLES EFG , 500 comprimidos | 10 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73600/73600_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73600/73600_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2011-08-30 | 1 | 1 | 1 | 2011-08-30 | 2011-08-30 | 1 | 2011-11-21 | View Edit Delete | ||||||||||||
| 605577 | 72709 | BOCOUTURE 50 UNIDADES POLVO PARA SOLUCION INYECTABLE | BOCOUTURE 50 UNIDADES POLVO PARA SOLUCION INYECTABLE , 6 viales | 50 U | 45 | 6 | 34 | 6 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72709/72709_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72709/72709_p.pdf | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1839 | MERZ AESTHETICS IBERIA S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2011-09-13 | 1 | 2012-10-29 | View Edit Delete | ||||||||||||
| 605578 | 67164 | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION , 10 viales de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 10 | 34 | 10 viales de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67164/67164_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67164/67164_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2005-11-02 | 1 | 1 | 1 | 2005-11-02 | 2011-09-13 | 1 | 2014-04-17 | View Edit Delete | ||||||||||||
| 605579 | 67164 | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION | PROPOFOL LIPOVEN FRESENIUS 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSION , 10 viales de 100 ml | 10 mg/ml inyectable 100 ml | 45 | 10 | 34 | 10 viales de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67164/67164_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67164/67164_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 2005-11-02 | 1 | 1 | 1 | 2005-11-02 | 2011-09-13 | 1 | 2014-04-17 | View Edit Delete | ||||||||||||
| 605583 | 62283 | CLORURO SODICO SERRA PAMIES 9 mg/ml DISOLVENTE PARA USO PARENTERAL | CLORURO SODICO SERRA PAMIES 9 mg/ml DISOLVENTE PARA USO PARENTERAL, 50 ampollas de 10 ml | 0,9% | 1 | 50 | 1 | 50 ampollas de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62283/62283_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62283/62283_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2001-04-03 | 1 | 1 | 1 | 2001-04-03 | 2011-10-03 | 0 | 2011-10-26 | View Edit Delete | ||||||||||||
| 605610 | 74947 | AIRE MEDICINAL SINTETICO OXIGEN SALUD 22% V/V GAS COMPRIMIDO MEDICINAL | AIRE MEDICINAL SINTETICO OXIGEN SALUD 22% V/V GAS COMPRIMIDO MEDICINAL, 12 balas de gas de 50 l (Bloque) | 22% v/v | 19 | 600 | 25 | 12 balas de gas de 50 l (Bloque) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74947/74947_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74947/74947_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 41184 | OXIGEN SALUD S.A. | 2011-11-08 | 1 | 1 | 1 | 2011-11-08 | 2011-11-08 | 0 | 2012-02-09 | View Edit Delete | ||||||||||||
| 605628 | 75042 | LEVETIRACETAM NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVETIRACETAM NORMON 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 500 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75042/75042_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75042/75042_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2011-11-23 | 1 | 1 | 1 | 2011-11-23 | 2011-11-23 | 1 | 2012-03-05 | View Edit Delete | ||||||||||||
| 605667 | 57864 | DEXTROSA FRESENIUS KABI 50% SOLUCION PARA PERFUSION | DEXTROSA FRESENIUS KABI 50% SOLUCION PARA PERFUSION, 12 frascos de 500 ml | 50% | 6 | 12 | 48 | 12 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57864/57864_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57864/57864_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1988-11-01 | 1 | 1 | 1 | 1988-11-01 | 2001-01-17 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 605675 | 64388 | AMOXICILINA NORMON 500 MG COMPRIMIDOS EFG | AMOXICILINA NORMON 500 MG COMPRIMIDOS EFG , 500 comprimidos | 500 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64388/64388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64388/64388_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-11-21 | 1 | 1 | 1 | 2001-11-21 | 2001-11-21 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 605677 | 74477 | PARACETAMOL KABI 10 mg/ml SOLUCION PARA PERFUSION EFG | PARACETAMOL KABI 10 mg/ml SOLUCION PARA PERFUSION EFG , 10 viales de 100 ml | 1.000 mg | 45 | 10 | 34 | 10 viales de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74477/74477_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74477/74477_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-12-12 | 1 | 1 | 1 | 2011-12-12 | 2011-12-12 | 1 | 2012-04-16 | View Edit Delete | ||||||||||||
| 605683 | 64389 | AMOXICILINA NORMON 750 MG COMPRIMIDOS EFG | AMOXICILINA NORMON 750 MG COMPRIMIDOS EFG , 500 comprimidos | 750 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64389/64389_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64389/64389_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-11-20 | 1 | 1 | 1 | 2001-11-20 | 2001-11-20 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 605710 | 74823 | VIAFLO BICARBONATO SODICO 1,4%, SOLUCION PARA PERFUSION | VIAFLO BICARBONATO SODICO 1,4%, SOLUCION PARA PERFUSION, 20 bolsas de 500 ml | 1,4% (1/6 M) | 3 | 20 | 65 | 20 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74823/74823_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74823/74823_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2011-12-29 | 1 | 1 | 1 | 2011-12-29 | 2011-12-29 | 0 | 2013-11-22 | View Edit Delete | ||||||||||||
| 605711 | 08472016 | XARELTO 15 mg COMPRIMIDOS RECUBIERTOS CON PELICULA (100 COMPRIMIDOS) | XARELTO 15 mg COMPRIMIDOS RECUBIERTOS CON PELICULA (100 COMPRIMIDOS), 100 comprimidos | 15 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08472016/08472016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08472016/08472016_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2012-01-03 | 1 | 1 | 1 | 2012-01-03 | 2012-01-03 | 1 | 2012-07-09 | View Edit Delete | ||||||||||||
| 605712 | 08472021 | XARELTO 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA (100 COMPRIMIDOS) | XARELTO 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA (100 COMPRIMIDOS), 100 comprimidos | 20 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08472021/08472021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08472021/08472021_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 26523 | BAYER HISPANIA S.L. | 2012-01-04 | 1 | 1 | 1 | 2012-01-04 | 2012-01-04 | 1 | 2012-07-09 | View Edit Delete | ||||||||||||
| 605733 | 64390 | AMOXICILINA NORMON 1000 MG COMPRIMIDOS EFG | AMOXICILINA NORMON 1000 MG COMPRIMIDOS EFG , 500 comprimidos | 1.000 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64390/64390_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64390/64390_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-11-21 | 1 | 1 | 1 | 2001-11-21 | 2001-11-21 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 605740 | 75265 | CARBOLIQ 200 mg/ ml SUSPENSION ORAL | CARBOLIQ 200 mg/ ml SUSPENSION ORAL, 10 frascos de 125 ml | 200 mg/ml | 6 | 1250 | 26 | 10 frascos de 125 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75265/75265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75265/75265_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2012-01-10 | 1 | 1 | 1 | 2012-01-10 | 2012-02-01 | 1 | 2012-06-19 | View Edit Delete | ||||||||||||
| 605742 | 75265 | CARBOLIQ 200 mg/ ml SUSPENSION ORAL | CARBOLIQ 200 mg/ ml SUSPENSION ORAL, 10 frascos de 250 ml | 200 mg/ml | 6 | 2500 | 26 | 10 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75265/75265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75265/75265_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2012-01-10 | 1 | 1 | 1 | 2012-01-10 | 2012-02-01 | 1 | 2012-06-19 | View Edit Delete | ||||||||||||
| 605743 | 75371 | MAGNESIA LAINCO 2,4 g SUSPENSION ORAL | MAGNESIA LAINCO 2,4 g SUSPENSION ORAL, 200 sobres de 12 ml | 2.400 mg | 35 | 200 | 64 | 200 sobres de 12 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75371/75371_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75371/75371_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2012-02-01 | 1 | 1 | 1 | 2012-02-01 | 2012-02-01 | 1 | 2012-05-07 | View Edit Delete | ||||||||||||
| 605747 | 75410 | PARACETAMOL KERN PHARMA 500 mg COMPRIMIDOS EFG | PARACETAMOL KERN PHARMA 500 mg COMPRIMIDOS EFG, 500 comprimidos | 500 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75410/75410_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75410/75410_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2012-02-07 | 1 | 1 | 1 | 2012-02-07 | 2012-02-07 | 0 | 2014-05-06 | View Edit Delete |
Page 14 of 1036, showing 20 records out of 20709 total, starting on record 261, ending on 280